Cite
332 - Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359).
MLA
Talano, Julie-An M., et al. “332 - Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359).” Biology of Blood & Marrow Transplantation, vol. 23, Mar. 2017, pp. S246–47. EBSCOhost, https://doi.org/10.1016/j.bbmt.2016.12.480.
APA
Talano, J.-A. M., Abikoff, C., Keever-Taylor, C. A., Walters, M. C., Shenoy, S., Moore, T. B., Parsons, S. K., Dozor, A. J., Friedman, D., Shi, Q., Braniecki, S., Grossman, B., Weinberg, R., Morris, E., Brand, P., Fabricatore, S., Ayello, J., Semidei-Pomales, M., Baxter-Lowe, L. A., & Cairo, M. S. (2017). 332 - Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359). Biology of Blood & Marrow Transplantation, 23, S246–S247. https://doi.org/10.1016/j.bbmt.2016.12.480
Chicago
Talano, Julie-An M., Cori Abikoff, Carolyn A. Keever-Taylor, Mark C. Walters, Shalini Shenoy, Theodore B. Moore, Susan K. Parsons, et al. 2017. “332 - Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359).” Biology of Blood & Marrow Transplantation 23 (March): S246–47. doi:10.1016/j.bbmt.2016.12.480.